More recently, markers associated with the NGF pathway, such as proNGF, plasminogen, neuroserpin, and MMP9 was shown to be elevated, whereas mNGF was downregulated in the brain tissue of MCI and AD patients (Pentz et al., 2020). The gene discussed is NGF; the disease is Alzheimer disease.